Essex BioTechnology
Status
INACTIVE
Global HQ
Hong Kong, China
Countries of investment
- Hong Kong
Investment stages
- Seed
Industries
- Biotechnology
- Health Tech
- AI
About
EssexBio is a global bio pharmaceutical company focused on Dermatology, Oncology, Ophthalmology, and Wound Healing, with a strong R&D presence and a wide range of products in over 10,000 hospitals.
EssexBio is a global bio pharmaceutical company focused on Dermatology, Oncology, Ophthalmology, and Wound Healing, with a strong R&D presence and a wide range of products in over 10,000 hospitals.
Investment Thesis
Essex BioTechnology focuses on the development, manufacturing, and commercialization of genetically engineered therapeutic drugs, particularly for the treatment of surface wounds and eye wounds.
Manager's Experience
With extensive experience in private equity, the fund manager has successfully executed numerous transactions across various sectors, including technology and healthcare. Active primarily in North America and Europe, they have built a diverse portfolio through over 30 deals, showcasing a keen ability to identify promising investment opportunities. Their strategic approach emphasizes a thematic focus, often prioritizing operator-first methodologies that leverage data-driven insights for value creation. Noteworthy exits underline their adeptness at navigating complex market landscapes, further solidifying their reputation in the investment community.
Portfolio
Wuhan Adv. Dental Bio-Technology
UNO Medical Group
Antikor Biopharma
Mitotech S.A.
Henlius
Humacyte